rs1057519864, AR

N. diseases: 8
Disease: Progressive Neoplastic Disease ×
Source: ALL
Disease Risk Allele Score vda Association Type Original DB Sentence supporting the association PMID PMID Year
Progressive Neoplastic Disease
CUI: C0677932
Disease: Progressive Neoplastic Disease
0.010 GeneticVariation BEFREE A missense mutation in the ligand-binding domain of the androgen receptor F876L confers resistance to the second-generation antiandrogens enzalutamide and ARN-509 in preclinical models of AR function and prostate cancer and is detected in plasma DNA from ARN-509-treated patients with progressive disease. 23779130 2013